--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood ...

(RTTNews) - Savara Inc. (SVRA), a biopharmaceutical company, Thursday announced that it has introduced the aPAP ClearPath Dried Blood Spot Test in the U.S. This new test builds on its prior serum ...

nnounced that it has completed submission of the BLA to the FDA for MOLBREEVI as a treatment for aPAP. Rani Therapeutics ... fusion to Sonnet's Fully Human Albumin Binding (FHAB®) platform ...

Organoids are stem-cell derived tissue structures mimicking specific structural and functional characteristics of human organs. Despite significant advancements in the field over the last decade, ...

在 DMN 和 APAP 诱导的肝损伤小鼠模型中 ... 和总胆红素（Total bilirubin，TBIL）的水平，增加了白蛋白（Albumin，ALB）的水平。组织学分析表明，RLTR - Wnt2@Exo CD47 治疗促进了肝细胞增殖，减少了肝脏坏死区域，降低了肝细胞死亡的发生率，同时减轻了炎症细胞的浸润。